151 related articles for article (PubMed ID: 8957074)
21. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
Wischnewski F; Friese O; Pantel K; Schwarzenbach H
Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428
[TBL] [Abstract][Full Text] [Related]
22. Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif.
Ragimov N; Krauskopf A; Navot N; Rotter V; Oren M; Aloni Y
Oncogene; 1993 May; 8(5):1183-93. PubMed ID: 8479742
[TBL] [Abstract][Full Text] [Related]
23. Fli-1b is generated by usage of differential splicing and alternative promoter.
Dhulipala PD; Lee L; Rao VN; Reddy ES
Oncogene; 1998 Sep; 17(9):1149-57. PubMed ID: 9764825
[TBL] [Abstract][Full Text] [Related]
24. In vivo modulation of ETS genes induced by electromagnetic fields.
Mucci N; Ianni A; Ursini CL; Arzani D; Bhat NK; Navarra P; Romano-Spica V
In Vivo; 2001; 15(6):489-94. PubMed ID: 11887334
[TBL] [Abstract][Full Text] [Related]
25. STAT1 and Nmi are downstream targets of Ets-1 transcription factor in MCF-7 human breast cancer cell.
Jung HH; Lee J; Kim JH; Ryu KJ; Kang SA; Park C; Sung K; Nam DH; Kang WK; Park K; Im YH
FEBS Lett; 2005 Jul; 579(18):3941-6. PubMed ID: 15996661
[TBL] [Abstract][Full Text] [Related]
26. Regulation of the human stress response gene GADD153 expression: role of ETS1 and FLI-1 gene products.
Seth A; Giunta S; Franceschil C; Kola I; Venanzoni MC
Cell Death Differ; 1999 Sep; 6(9):902-7. PubMed ID: 10510472
[TBL] [Abstract][Full Text] [Related]
27. Wild-type p53 down-regulates transcription from oncogenic human papillomavirus promoters through the epithelial specific enhancer.
Desaintes C; Hallez S; Detremmerie O; Burny A
Oncogene; 1995 Jun; 10(11):2155-61. PubMed ID: 7784059
[TBL] [Abstract][Full Text] [Related]
28. Parathyroid hormone-related protein gene expression in human squamous carcinoma cells is repressed by mutant isoforms of p53.
Foley J; Wysolmerski JJ; Broadus AE; Philbrick WM
Cancer Res; 1996 Sep; 56(17):4056-62. PubMed ID: 8752179
[TBL] [Abstract][Full Text] [Related]
29. [Transcription factors of the Ets family and morphogenesis of the vascular tree].
Mattot V; Vercamer C; Soncin F; Fafeur V; Vandenbunder B
J Soc Biol; 1999; 193(2):147-53. PubMed ID: 10451348
[TBL] [Abstract][Full Text] [Related]
30. Mouse models in the study of the Ets family of transcription factors.
Bartel FO; Higuchi T; Spyropoulos DD
Oncogene; 2000 Dec; 19(55):6443-54. PubMed ID: 11175360
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B virus X gene expression is activated by X protein but repressed by p53 tumor suppressor gene product in the transient expression system.
Takada S; Kaneniwa N; Tsuchida N; Koike K
Virology; 1996 Feb; 216(1):80-9. PubMed ID: 8615009
[TBL] [Abstract][Full Text] [Related]
32. Cell-specific modulation of the papovavirus promoters by tumor-suppressor protein p53 in the absence of large T-antigen.
Das GC; Shivakumar CV; Todd SD
Oncogene; 1995 Feb; 10(3):449-55. PubMed ID: 7845669
[TBL] [Abstract][Full Text] [Related]
33. ets-1 and ets-2 proto-oncogene expression in human leukemia cells and cell lines.
Dreyfus F; Picard F; Gisselbrecht S; Varet B; Tambourin PE; Fichelson S
Nouv Rev Fr Hematol (1978); 1989; 31(3):217-21. PubMed ID: 2694094
[TBL] [Abstract][Full Text] [Related]
34. Distinct regions of p53 have a differential role in transcriptional activation and repression functions.
Sang BC; Chen JY; Minna J; Barbosa MS
Oncogene; 1994 Mar; 9(3):853-9. PubMed ID: 8108128
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein.
Farmer G; Friedlander P; Colgan J; Manley JL; Prives C
Nucleic Acids Res; 1996 Nov; 24(21):4281-8. PubMed ID: 8932384
[TBL] [Abstract][Full Text] [Related]
36. The H19 TATA-less promoter is efficiently repressed by wild-type tumor suppressor gene product p53.
Dugimont T; Montpellier C; Adriaenssens E; Lottin S; Dumont L; Iotsova V; Lagrou C; Stéhelin D; Coll J; Curgy JJ
Oncogene; 1998 May; 16(18):2395-401. PubMed ID: 9620557
[TBL] [Abstract][Full Text] [Related]
37. p53 represses SV40 transcription by preventing formation of transcription complexes.
Perrem K; Rayner J; Voss T; Sturzbecher H; Jackson P; Braithwaite A
Oncogene; 1995 Oct; 11(7):1299-307. PubMed ID: 7478550
[TBL] [Abstract][Full Text] [Related]
38. "Oncogenes as probes for cellular signal processes: the family of ETS genes".
Papas TS
AIDS Res Hum Retroviruses; 1992 May; 8(5):824-33. PubMed ID: 1515233
[No Abstract] [Full Text] [Related]
39. MafB represses erythroid genes and differentiation through direct interaction with c-Ets-1.
Sieweke MH; Tekotte H; Frampton J; Graf T
Leukemia; 1997 Apr; 11 Suppl 3():486-8. PubMed ID: 9209434
[TBL] [Abstract][Full Text] [Related]
40. Regulation of transcription of the human presenilin-1 gene by ets transcription factors and the p53 protooncogene.
Pastorcic M; Das HK
J Biol Chem; 2000 Nov; 275(45):34938-45. PubMed ID: 10942770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
